Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and hospice enrollment, escalates costs, and may adversely affect the quality of care patients receive. Accordingly, over ...
Oct 21, 2022
0
36
Newly published research carried out using synthetic human bone marrow cells is paving the way for the development of safer and kinder treatments for children with leukemia.
Aug 17, 2022
0
56
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, ...
Jun 2, 2022
0
77
Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma. ...
Dec 10, 2021
0
46
Treatment with arginine, one of the amino-acid building blocks of proteins, enhanced the effectiveness of radiation therapy in cancer patients with brain metastases, in a proof-of-concept, randomized clinical trial from investigators ...
Nov 5, 2021
0
269
Researchers from Boston University School of Medicine (BUSM) have identified proteins that are essential for the viability of whole genome doubled tumor cells, yet non-essential to normal cells that comprise the majority ...
Jan 27, 2021
0
37
A study from Emory Vaccine Center provides insights into why the boost in immunity from seasonal flu vaccination lasts for months but not years, unlike some childhood vaccinations.
Aug 13, 2020
0
70
Tiny finger-like projections called filopodia drive invasive behavior in a rare subset of lung cancer cells, researchers at Winship Cancer Institute of Emory University have found.
Jul 27, 2020
0
67
Oncology patients would prefer to be asked for their consent before deidentified data from their medical records is used for research, according to a study recently published in the Journal of Clinical Oncology.
Nov 20, 2019
0
24
The checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a new global study led by Yale Cancer Center (YCC). The data was published today ...
Nov 4, 2019
0
26
